Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 12, 2025Exploration of Targeted Anti-tumor TherapyOpen Access

Improvement of the sensitivity of circulating tumor DNA-based liquid biopsy: current approaches and future perspectives

View Full Paper
Ask AI
Bookmark
Share

Authors

EKEkatherina Sh. KuliginaGYGrigoriy A. YanusEIEvgeny N. Imyanitov

Discussion

Loading...

Member takes

Overview

Current approaches improve ctDNA detection in liquid biopsy, highlighting interlaboratory harmonization needs.

Key Points

  • Improving sensitivity of ctDNA in liquid biopsy is crucial for early cancer diagnosis and prognosis.
  • High ctDNA levels typically signal increased tumor burden and poorer outcomes, emphasizing detection importance.
  • Enhanced protocols like ultra-deep NGS help distinguish true mutations from artifacts in ctDNA tests.
  • Ensuring reproducibility through interlaboratory harmonization is vital for effective ctDNA-based diagnostics.

Cite This Study

Kuligina et al. (2025) studied this question.

synapsesocial.com/papers/68c23595b210217d6477129dhttps://doi.org/10.37349/etat.2025.1002333
View Full Paper
Ask AI
Bookmark
Share